Physician profile
John Pappas
NPI 1952340598
$3,854.63
in general payments reported to CMS, 2019-2025
18 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.38 · 2020: $63.90 · 2021: $1,583 · 2022: $887 · 2023: $648 · 2024: $314 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,021.07 | 2021-2023 | Alto Abdominal Stent Graft System |
| Cook Medical LLC | $422.74 | 2022-2024 | Zilver Ptx, Zilver Vena, Rosen |
| Inari Medical, INC. | $414.59 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $198.74 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $167.57 | 2022-2023 | Indigo System |
| Boston Scientific Corporation | $130.23 | 2024-2025 | Watchman Access System, Watchman Flx, Eluvia |
| Medtronic, INC. | $104.46 | 2022-2024 | Hawkone |
| Chiesi USA, INC. | $75.97 | 2019-2021 | |
| Abbott Laboratories | $75.69 | 2023 | Supera |
| Angiodynamics, INC. | $55.00 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $53.93 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $27.54 | 2020-2021 | |
| Edwards Lifesciences Corporation | $23.79 | 2025 | Sapien 3 Ultra Resilia |
| Ethicon US, LLC | $21.98 | 2019 | |
| Medtronic Vascular, INC. | $20.19 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.97 | 2020 | |
| Covidien LP | $12.17 | 2019 | |
| Zoll Circulation INC | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pappas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.